TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Route of Administration Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Controlled Release Drug Delivery Market, by Route of Administration
6.1 Introduction
6.2 Oral
6.3 Injectable
6.3.1 Targeted Delivery
6.3.2 Transmucosal
6.3.3 Transdermal
6.4 Ocular
6.5 Nasal
6.6 Topical
6.7 Implantable
Chapter 7. Global Controlled Release Drug Delivery Market, by Release Mechanism
7.1 Introduction
7.2 Polymer-based Drug Delivery Systems
7.3 Micro reservoir Partition Controlled Drug Delivery Systems
7.4 Feedback Regulated Drug Delivery Systems
7.5 Activation Modulated Drug Delivery Systems
7.5.1 Osmotic Pressure Activated drug delivery
7.5.2 Hydrodynamic Pressure Activated drug delivery
7.5.3 Vapor Pressure Activated drug delivery
7.5.4 Mechanically Activated drug
7.5.5 Magnetically Activated drug
7.6 Chemically Activated Controlled Drug Delivery Systems
7.6.1 pH Activated Drug Delivery
7.6.2 Hydrolysis Activated Drug Delivery
7.6.3 Enzyme Activated Drug Delivery
Chapter 8. Global Controlled Release Drug Delivery Market, by Products
8.1 Metered Dose Inhalers,
8.2 Needle-Free injectors
8.3 Auto-injectors
8.4 Nasal sprays
8.5 Transdermal Patchez
8.6 Nebulizers
8.7 Infusion Pumps
8.8 Drug-Eluting Stents
8.9 Sustained Release
8.10 Ocular Implants
Chapter 9. Global Controlled Release Drug Delivery Market, by End User
9.1 Introduction
9.2 Hospital and Clinics
9.3 Personal Use
9.4 Research Centers
9.5 Others
Chapter 10. Global Controlled Release Drug Delivery Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
10.6. Company Landscape
10.6.1 Introduction
10.6.2 Market Share Analysis
10.6.3 Key Development & Strategies
10.6.3.1 Key Developments
Chapter 11 Company Profiles
11.1 DEPOMED, INC.
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financials
11.2.4 Key Developments
11.1.5 SWOT Analysis
11.2 Coating Place, Inc
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Corium International Inc.
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Alza Corporation (Johnson & Johnson)
11.4.1 Company Overview
11.4.2 Type/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 PFIZER INC.
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 SKY Pharmaceuticals Pvt. Ltd.
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 AstraZeneca
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 BIOGEN
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 GlaxoSmithKline
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Novartis
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Allergan
11.11.1 Overview
11.11.2 Type Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Collegium Pharmaceutical
11.11.1 Overview
11.11.2 Type Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.13 Others
Chapter 12 Appendix
LIST OF TABLES
Table 1 Global Controlled Release Drug Delivery Market Industry Synopsis, 2020–2027
Table 2 Global Controlled Release Drug Delivery Market Estimates & Forecast, 2020–2027, (USD Million)
Table 3 Global Controlled Release Drug Delivery Market, by Region, 2020–2027, (USD Million)
Table 4 Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 5 Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 6 Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 7 Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 8 North America: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 9 North America: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 10 North America: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 11 North America: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 12 US: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 13 US: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 14 US: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 15 US: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 16 Canada: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 17 Canada: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 18 Canada: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 19 Canada: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 20 South America: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 21 South America: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 22 South America: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million
Table 23 South America: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 24 Europe: Global Controlled Release Drug Delivery Market, Route of Administration, 2020–2027, (USD Million)
Table 25 Europe: Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 26 Europe: Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 27 Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 28 Western Europe: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 29 Western Europe: Global Controlled Release Drug Delivery Market, by Release Mechanism ,2020 –2027, (USD Million)
Table 30 Western Europe: Global Controlled Release Drug Delivery Market, by Products,2020 –2027, (USD Million)
Table 31 Western Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 32 Eastern Europe: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 33 Eastern Europe: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 34 Eastern Europe: Global Controlled Release Drug Delivery Market, by Patent Type, 2020 –2027, (USD Million)
Table 35 Eastern Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 36 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 37 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 38 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 39 Asia-Pacific: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
Table 40 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)
Table 41 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)
Table 42 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)
Table 43 Middle East & Africa: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Products
Figure 2 Market structure for the Global Controlled Release Drug Delivery Market
Figure 3 Market Dynamics for the Global Controlled Release Drug Delivery Market
Figure 4 Global Controlled Release Drug Delivery Market Share, by Route of Administration 2020
Figure 5 Global Controlled Release Drug Delivery Market Share, by Release Mechanism, 2020
Figure 6 Global Controlled Release Drug Delivery Market Share, by Products, 2020
Figure 7 Global Controlled Release Drug Delivery Market Share, by End-User, 2020
Figure 8 Global Controlled Release Drug Delivery Market Share, by Region, 2020
Figure 9 North America Global Controlled Release Drug Delivery Market Share, by Country, 2020
Figure 10 Europe Prescribed Health Apps Share, by Country, 2020
Figure 11 Asia-Pacific Global Controlled Release Drug Delivery Market Share, by Country, 2020
Figure 12 Middle East & Africa Global Controlled Release Drug Delivery Market Share, by Country, 2020
Figure 13 Global Controlled Release Drug Delivery Market: Company Share Analysis, 2020 (%)
Figure 14 DEPOMED, INC.: Key Financials
Figure 15 DEPOMED, INC.: Segmental Revenue
Figure 16 DEPOMED, INC.: Geographical Revenue
Figure 17 Coating Place, Inc: Key Financials
Figure 18 Coating Place, Inc: Segmental Revenue
Figure 19 Coating Place, Inc: Geographical Revenue
Figure 20 Corium International Inc.: Key Financials
Figure 21 Corium International Inc.: Segmental Revenue
Figure 22 Corium International Inc.: Geographical Revenue
Figure 23 Alza Corporation (Johnson & Johnson): Key Financials
Figure 24 Alza Corporation (Johnson & Johnson): Segmental Revenue
Figure 25 Alza Corporation (Johnson & Johnson): Geographical Revenue
Figure 26 PFIZER INC.: Key Financials
Figure 27 PFIZER INC.: Segmental Revenue
Figure 28 PFIZER INC.: Geographical Revenue
Figure 29 SKY Pharmaceuticals Pvt. Ltd.: Key Financials
Figure 30 SKY Pharmaceuticals Pvt. Ltd.: Segmental Revenue
Figure 31 SKY Pharmaceuticals Pvt. Ltd.: Geographical Revenue
Figure 32 AstraZeneca: Key Financials
Figure 33 AstraZeneca: Segmental Revenue
Figure 34 AstraZeneca: Geographical Revenue
Figure 35 Biogen: Key Financials
Figure 36 Biogen: Segmental Revenue
Figure 37 Biogen: Geographical Revenue
Figure 38 GlaxoSmithKline: Key Financials
Figure 39 GlaxoSmithKline: Segmental Revenue
Figure 40 GlaxoSmithKline: Geographical Revenue
Figure 41 Novartis: Key Financials
Figure 42 Novartis: Segmental Revenue
Figure 43 Novartis: Geographical Revenue
Figure 44 Allergan: Key Financials
Figure 45 Allergan: Segmental Revenue
Figure 46 Allergan: Geographical Revenue
Figure 47 Collegium Pharmaceutical: Key Financials
Figure 48 Collegium Pharmaceutical: Segmental Revenue
Figure 49 Collegium Pharmaceutical: Geographical Revenue
